Search

Author/Creator Hylemon, P. B.

1. HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients. Issue 6 (15th July 2016)

Authors:
Bajaj, J. S.; Sterling, R. K.; Betrapally, N. S.; Nixon, D. E.; Fuchs, M.; Daita, K.; Heuman, D. M.; Sikaroodi, M.; Hylemon, P. B.; White, M. B.; Ganapathy, D.; Gillevet, P. M.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 44:Issue 6(2016)
Page Start:
638
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Issue 10 (16th March 2014)

Authors:
Bajaj, J. S.; Heuman, D. M.; Hylemon, P. B.; Sanyal, A. J.; Puri, P.; Sterling, R. K.; Luketic, V.; Stravitz, R. T.; Siddiqui, M. S.; Fuchs, M.; Thacker, L. R.; Wade, J. B.; Daita, K.; Sistrun, S.; White, M. B.; Noble, N. A.; Thorpe, C.; Kakiyama, G.; Pandak, W. M.; Sikaroodi, M.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 39:Issue 10(2014)
Page Start:
1113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search